SwissClinical Research
Why Switzerland
Switzerland stands out as a clinical research destination
Thanks to its internationally renowned healthcare system, rigorous regulatory environment, and exceptional medical expertise.
Swiss hospitals and research institutions
Equipped with advanced, state-of-the-art facilities, enabling clinical trials that consistently meet the highest international standards of quality and patient safety.
The Swiss regulatory framework
Globally recognized for its scientific rigor, clarity, and predictability. This stability creates a robust foundation for clinical studies aiming for reliable outcomes and regulatory acceptance worldwide.
With its highly specialized workforce
Switzerland excels in conducting clinical trials across diverse therapeutic areas, particularly those requiring precise, high-quality data and expert clinical oversight.
Beyond clinical trials
Switzerland is a strategic and commercially significant market for your approved medicines.
#1 Global Innovation Index
Switzerland ranks first on the Global Innovation Index, reflecting its strong capacity to translate innovation into applied research.
The GALSER Network
GALSER’s network provides facilitated access to Switzerland’s renowned healthcare and research infrastructure. Our partnerships with leading hospitals and specialized clinics enable direct collaboration with Key Opinion Leaders (KOLs) and expert investigators across multiple therapeutic areas, significantly enhancing patient recruitment and data quality.
We also work closely with prominent Swiss universities and both public and private research centers, enabling the integration of advanced scientific insights into your clinical programs.
Our relationships with patient associations further enrich studies by aligning clinical outcomes with patient needs and experiences, in line with patient involvement.
Additionally, our active participation in Switzerland’s life sciences ecosystem, including regular interactions with regulatory authorities, ensures effective navigation through clinical development and approval processes.
By leveraging this robust and targeted network, GALSER is uniquely positioned to support your clinical research objectives in Switzerland.
FAQ
Feedback from our clients
“GALSER team has shown a great mix of professionalism, flexibility/adaptability and profound knowledge of the human research landscape in Switzerland”
01
/05
“The GALSER team guided us through the Swiss regulatory process with clear advice and great responsiveness. Their support made the entire submission much easier than we anticipated.”
02
/05
“We were impressed by GALSER’s strong relationships with the study sites and their ability to keep things moving despite the usual challenges. It really helped us stay on track”
03
/05
“Your level of detail and expertise really stand out. It’s been a real pleasure working together!”
04
/05
“A remarkable project leader who managed to deliver a high-quality protocol in a very short time”
05
/05
